CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

28 hedge funds and large institutions have $56.7M invested in Cymabay Therapeutics in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
8
Reduced
5
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
ARTA
26
A.R.T. Advisors
New York
$104K +$104K +15,129 New
PP
27
PDT Partners
New York
$87K +$87K +12,500 New
Manulife (Manufacturers Life Insurance)
28
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2
SAM
29
Sectoral Asset Management
Quebec, Canada
-$6.97M -708,585 Closed
SCM
30
Sio Capital Management
New York
-$1.2M -121,900 Closed
RSCM
31
Rock Springs Capital Management
Maryland
-$983K -100,000 Closed
Goldman Sachs
32
Goldman Sachs
New York
-$418K -42,563 Closed
ClearBridge Investments
33
ClearBridge Investments
New York
-$17K -1,760 Closed
Citigroup
34
Citigroup
New York
-$5K -482 Closed
UBS Group
35
UBS Group
Switzerland
-$3K -329 Closed
Deutsche Bank
36
Deutsche Bank
Germany
-$2K -300 Closed